OTCMKTS:RCPIQ - Rock Creek Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.0006 0.00 (0.00 %) (As of 08/21/2018 03:57 AM ET)Previous Close$0.0010Today's Range$0.0006 - $0.000652-Week Range$0.0004 - $0.02Volume128 shsAverage Volume141,565 shsMarket Capitalization$150,000.00P/E RatioN/ADividend YieldN/ABeta2.03 Company ProfileChartEarnings HistoryInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware. Receive RCPIQ News and Ratings via Email Sign-up to receive the latest news and ratings for RCPIQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical SymbolOTCMKTS:RCPIQ CUSIPN/A Webwww.rockcreekpharmaceuticals.com Phone844-727-0727 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares170,450,000Market Cap$150,000.00 Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) Frequently Asked Questions What is Rock Creek Pharmaceuticals' stock symbol? Rock Creek Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RCPIQ." How were Rock Creek Pharmaceuticals' earnings last quarter? Rock Creek Pharmaceuticals Inc (OTCMKTS:RCPIQ) posted its quarterly earnings results on Monday, November, 11th. The company reported ($0.02) earnings per share (EPS) for the quarter. The firm had revenue of $2.26 million for the quarter, compared to the consensus estimate of $1.70 million. View Rock Creek Pharmaceuticals' Earnings History. Who are some of Rock Creek Pharmaceuticals' key competitors? Some companies that are related to Rock Creek Pharmaceuticals include Actelion (ALIOF), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Tilray (TLRY), Chromadex (CDXC), Foamix Pharmaceuticals (FOMX), Mediwound (MDWD), Natural Alternatives International (NAII), Pharmacyte Biotech (PMCB), Mannatech (MTEX), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), ImmuDyne (IMMD) and FitLife Brands (FTLF). Who are Rock Creek Pharmaceuticals' key executives? Rock Creek Pharmaceuticals' management team includes the folowing people: Dr. Michael John Mullan MBBS (M.D., ), Ph.D., Chairman, Chief Exec. Officer and Pres (Age 61)Dr. Curtis Wright IV, Sr. VP and Medical & Clinical Director (Age 69)Mr. Richard Milam, Director of Quality Assurance & New Product Devel. Has Rock Creek Pharmaceuticals been receiving favorable news coverage? News headlines about RCPIQ stock have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Rock Creek Pharmaceuticals earned a daily sentiment score of 0.09 on Accern's scale. They also gave press coverage about the company an impact score of 47.21 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next several days. View Recent Headlines for Rock Creek Pharmaceuticals. How do I buy shares of Rock Creek Pharmaceuticals? Shares of RCPIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Rock Creek Pharmaceuticals' stock price today? One share of RCPIQ stock can currently be purchased for approximately $0.0006. How big of a company is Rock Creek Pharmaceuticals? Rock Creek Pharmaceuticals has a market capitalization of $150,000.00. How can I contact Rock Creek Pharmaceuticals? Rock Creek Pharmaceuticals' mailing address is 2040 WHITFIELD AVE. SUITE 300, SARASOTA FL, 34243. The company can be reached via phone at 844-727-0727 or via email at [email protected] MarketBeat Community Rating for Rock Creek Pharmaceuticals (OTCMKTS RCPIQ)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 42 (Vote Outperform)Underperform Votes: 45 (Vote Underperform)Total Votes: 87MarketBeat's community ratings are surveys of what our community members think about Rock Creek Pharmaceuticals and other stocks. Vote "Outperform" if you believe RCPIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCPIQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 8/21/2018 by MarketBeat.com StaffFeatured Article: What does earnings per share mean?